Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy – a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial

INTRODUCTION: Contrast-induced nephropathy (CIN) is a common clinical problem that is growing in importance as an increasing number of tests and procedures which utilize contrast media (CM) are performed. AIM: To evaluate the efficacy of intravenous N-acetylcysteine (NAC) for prevention of CIN after...

Descripción completa

Detalles Bibliográficos
Autores principales: Biernacka-Fiałkowska, Barbara, Szuksztul, Marta, Suślik, Wojciech, Dzierwa, Karolina, Tekieli, Łukasz, Kostkiewicz, Magdalena, Podolec, Piotr, Pieniążek, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939546/
https://www.ncbi.nlm.nih.gov/pubmed/29743905
http://dx.doi.org/10.5114/aic.2018.74356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5939546/
https://www.ncbi.nlm.nih.gov/pubmed/29743905
http://dx.doi.org/10.5114/aic.2018.74356

Ejemplares similares